Dr. Kinsey A. Cornick, DO

Dr. Cornick practices at New York Institute of Technology in Jonesboro, Arkansas.

Dr. Cornick's NPI, 1306339502, was assigned on June 12, 2018. Dr. Cornick holds Minnesota license 69461.

Dr. Cornick's primary practice is New York Institute of Technology, at 333 Red Wolf Blvd, Jonesboro, AR 72405 in Craighead County. The practice phone is (870) 972-2054.

Dr. Cornick's primary practice is New York Institute of Technology in Jonesboro, Arkansas. The medical group on file is NYITCOM Medical Clinic. Dmand AI also links Dr. Cornick to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cornick practices. Vendor and product names are available with a free account.

Family medicine is Dr. Cornick's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dmand AI has Dr. Cornick's licenses on file in 2 states: Minnesota and Missouri.

CMS data shows 52 Medicare services from Dr. Cornick across 2 procedure codes in 2024, all of them office visits, for 37 Medicare patients. Medicare paid $3,131 for them. Every service was in an office.

CMS counts 37 Medicare patients who saw Dr. Cornick in 2024. The largest group is 65 to 74, with 13 patients. 73% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cornick's median patient age at 28, with 54% women.

In 2024, Dr. Cornick wrote 1,043 Medicare Part D claims for 162 patients. 89% of them were for generic drugs. CMS names the drug for 735 of them, across 22 drugs with 11 or more claims each, at $23,214 in total drug cost. In 2023, CMS named 1,268 claims across 39 drugs.

Dr. Cornick accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Cornick from 2 drug and device companies from 2019 to 2021. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $16.